Lead Product(s) : Cannabinoid,Tetrahydrocannabinol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Avicanna
Deal Size : Undisclosed
Deal Type : Agreement
Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.
Details : Avicanna and Knop have developed a collaborative enterprise which has led to commercial imports of Avicanna´s API, including CBD and THC, which has been used in the development, production and commercialization of several cannabinoid-based products.
Product Name : Cannabiol
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 14, 2022
Lead Product(s) : Cannabinoid,Tetrahydrocannabinol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Avicanna
Deal Size : Undisclosed
Deal Type : Agreement
Details : Knopp has developed a discovery platform of molecules directed to a non-opioid biological target linked to chronic pain caused by nerves damage. The drug target is Kv7.2/7.3 which regulates the flow of electrically charged ions required to modulate the e...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 10, 2020
Lead Product(s) : KB-3061
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Knopp is advancing the development of KB-3061 as a potential precision medicine for KCNQ2-EE, a rare genetic disease associated with seizures beginning in the first days of life and profound neurodevelopmental delay.
Product Name : KB-3061
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 15, 2020
Lead Product(s) : KB-3061
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
